With over 4 million people affected across Argentina, migraines are far more than just severe headaches; they are debilitating neurological conditions. Through the newly available MIDAS questionnaire, patients can now transform their daily struggles into concrete data to optimize neurological treatments and reclaim their quality of life.

Beyond the Headache: Migraine as an Invisible Disability

For many, a migraine is dismissed as a simple "bad headache," but in reality, it is a complex neurological condition that can severely impair a person's ability to function. According to reports from Diario El Norte, this condition affects approximately 1 in 10 people in Argentina, totaling more than 4 million citizens.

Who is most affected?

The statistics are striking: 3 out of 4 cases occur in women. Beyond the throbbing pain, these crises are often accompanied by nausea, vomiting, and acute sensitivity to light (known as photophobia) and sound (phonophobia).

The MIDAS Questionnaire

The Migraine Disability Assessment (MIDAS) is a specialized tool designed to quantify the functional impact of the disease. Now available for free at www.aliasmigraña.com, this test consists of 7 questions focusing on the patient's experience over the last three months.

The system evaluates four critical dimensions of life:

  • ✅ Work or academic performance.
  • ✅ Ability to perform household chores.
  • ✅ Quality of family and social life.
  • ✅ Frequency and intensity of the pain.

Results and Classification

Upon completing the test, users can download a PDF report detailing their impact level, classified as follows:

Impact Level Meaning
None / Minimal Imperceptible impact on daily routine.
Mild Occasional discomfort.
Moderate Frequent interference with activities.
Severe Profound limitation of quality of life.

*Important: This tool is for guidance only and does not replace a diagnosis from a licensed neurologist.

Expert Insights: The Hidden Toll

Dr. Natalia Larripa highlights a crucial concept: "Presenteeism." This occurs when a patient physically attends their workplace but performs at half their usual capacity (or less) due to pain—a reality that often goes unnoticed by employers and colleagues.

Furthermore, experts warn against the "naturalization of pain," where patients begin to abandon physical activities or isolate themselves socially to avoid triggers, silently shrinking their world. The ultimate goal of the MIDAS test is to turn these invisible limitations into objective data, allowing neurologists to establish personalized strategies for both crisis control and preventive treatment.